Litium Q1: In line with expectations - ABG
ARR +7% y-o-y, in line with ABGSCe
Cons. likely to make minor neg. est. revisions
Webcast scheduled for 11:00 CET
Q1'23 results
ARR SEK 70.1m (+/-0% vs. ABGSCe 70.2m), net sales SEK 15.5m (-5% vs. ABGSCe 16.2m), EBITDA SEK 0.6m (vs. ABGSCe 1.7m), EBIT SEK -3.1m (vs. ABGSCe -1.5m), net profit SEK -3.1m (vs. ABGSCe -1.5m). With respect to ARR, the report was in line with expectations. The migration effect amounted to SEK -1.8m on ARR, meaning that an adjusted ARR would amount to SEK 71.9m. However, sales and EBITDA came in slightly below our estimates, and this deviation is therefore explained mostly by operating leverage.
Länk till analysen i sin helhet: https://cr.abgsc.com/foretag/Litium/Equity-research/2023/4/litium---q1-in-line-with-expectations/